Altered	O
SOX9	B-ENHANCER
genital	I-ENHANCER
tubercle	I-ENHANCER
enhancer	I-ENHANCER
region	E-ENHANCER
in	O
hypospadias	O
.	O


Human	O
mutations	O
in	O
the	O
SOX9	O
gene	O
or	O
its	O
regulatory	O
region	O
can	O
disrupt	O
testicular	O
development	O
,	O
leading	O
to	O
disorders	O
of	O
sex	O
development	O
(	O
DSDs	O
)	O
.	O


Our	O
previous	O
work	O
involving	O
the	O
genomic	O
analysis	O
of	O
isolated	O
DSD	O
patients	O
revealed	O
a	O
78kb	O
minimal	O
sex	O
determining	O
region	O
(	O
RevSex	O
)	O
far	O
upstream	O
of	O
SOX9	O
that	O
was	O
duplicated	O
in	O
46	O
,	O
XX	O
and	O
deleted	O
in	O
46	O
,	O
XY	O
DSDs	O
.	O


It	O
was	O
postulated	O
that	O
RevSex	O
contains	O
a	O
gonadal	B-ENHANCER
enhancer	E-ENHANCER
.	O


However	O
,	O
the	O
most	O
highly	O
conserved	O
sub	O
-	O
region	O
within	O
RevSex	O
,	O
called	O
SR4	O
,	O
was	O
neither	O
responsive	O
to	O
sex	O
determining	O
factors	O
in	O
vitro	O
nor	O
active	O
in	O
the	O
gonads	O
of	O
transgenic	O
mice	O
,	O
suggesting	O
that	O
SR4	O
may	O
not	O
be	O
functioning	O
as	O
a	O
testicular	B-ENHANCER
enhancer	E-ENHANCER
.	O


Interestingly	O
,	O
SR4	O
transgenic	O
mice	O
showed	O
reporter	O
activity	O
in	O
the	O
genital	O
tubercle	O
,	O
the	O
primordium	O
of	O
the	O
penis	O
and	O
clitoris	O
,	O
a	O
previously	O
unreported	O
domain	O
of	O
Sox9	O
expression	O
.	O


SOX9	O
protein	O
was	O
detected	O
in	O
the	O
genital	O
tubercle	O
,	O
notably	O
in	O
the	O
urethral	O
plate	O
epithelium	O
,	O
preputial	O
glands	O
,	O
ventral	O
surface	O
ectoderm	O
and	O
corpus	O
cavernosa	O
.	O


SR4	O
may	O
therefore	O
function	O
as	O
a	O
Sox9	B-ENHANCER
genital	I-ENHANCER
tubercle	I-ENHANCER
enhancer	E-ENHANCER
,	O
mutations	O
of	O
which	O
could	O
possibly	O
lead	O
to	O
hypospadias	O
,	O
a	O
birth	O
defect	O
seen	O
in	O
the	O
DSD	O
patients	O
in	O
the	O
RevSex	O
study	O
.	O


SR4	O
activity	O
and	O
the	O
observed	O
SOX9	O
expression	O
pattern	O
suggest	O
that	O
SR4	O
may	O
function	O
as	O
a	O
Sox9	B-ENHANCER
genital	I-ENHANCER
tubercle	I-ENHANCER
enhancer	E-ENHANCER
.	O


However	O
,	O
conditional	O
ablation	O
of	O
Sox9	O
in	O
the	O
genital	O
tubercle	O
using	O
Shh	O
-	O
Cre	O
/	O
+	O
;	O
Sox9flox	O
/	O
flox	O
mice	O
revealed	O
no	O
genital	O
tubercle	O
abnormalities	O
,	O
possibly	O
due	O
to	O
compensation	O
by	O
similar	O
Sox	O
factors	O
.	O


To	O
conclude	O
,	O
we	O
have	O
identified	O
a	O
novel	O
regulatory	B-ENHANCER
enhancer	E-ENHANCER
driving	O
Sox9	O
expression	O
during	O
external	O
genitalia	O
development	O
.	O
